Ambulatory blood pressure monitoring in the TRU Sleep Clinic: Should high blood pressure and sleep apnea be tested for and treated simultaneously? by Holtslag, Kayla Ann (author) et al.
  
Faculty of Science 
 
AMBULATORY BLOOD PRESSURE MONITORING IN THE TRU SLEEP CLINIC: 
SHOULD HIGH BLOOD PRESSURE AND SLEEP APNEA BE TESTED FOR AND 
TREATED SIMULTANEOUSLY? 
 
2014  |   KAYLA ANN HOLTSLAG 
B.Sc. Honours thesis 
i 
 
AMBULATORY BLOOD PRESSURE MONITORING IN THE TRU SLEEP CLINIC: 
SHOULD HIGH BLOOD PRESSURE AND SLEEP APNEA BE TESTED FOR AND 
TREATED SIMULTANEOUSLY? 
 
by 
 
KAYLA ANN HOLTSLAG 
 
A THESIS SUBMITTED IN PARTIAL FULFILLMENT  
OF THE REQUIREMENTS FOR THE DEGREE OF  
BACHELOR OF SCIENCE (HONS.) 
in the 
DEPARTMENT OF BIOLOGICAL SCIENCES  
(Cellular, Molecular, and Microbial Biology) 
 
 
 
We accept this thesis as conforming to the required standards: 
 
_________________________________________ 
Nancy Flood (Ph.D.), Thesis Supervisor, Dept. Biological Sciences 
 
_________________________________________ 
Les Matthews, Co-supervisor, Dept. Respiratory Therapy 
 
__________________________________________ 
Jonathan Van Hamme (Ph.D.), Dept. Biological Sciences 
 
Dated this 22nd day of April, 2014, in Kamloops, British Columbia, Canada 
  
ii 
 
 
ABSTRACT 
Extensive research has demonstrated a strong correlation between obstructive sleep 
apnea (OSA) and high blood pressure (hypertension). Furthermore, studies have shown 
that treating OSA can lead to an improvement in blood pressure levels. Despite this 
knowledge, many sleep clinics still do not test their patients for hypertension and have 
yet to develop comprehensive treatment plans that aim to target both OSA and 
hypertension. The TRU Sleep Clinic currently sees patients referred by local physicians 
for overnight ambulatory blood pressure (ABP) monitoring; upon their first visit, the 
patients are questioned regarding their sleep habits and complete questionnaires 
designed to reveal the level of risk for OSA. Despite this effort, patients are not 
returning to the clinic for further screening and treatment for OSA. The purpose of this 
study was to identify ABP patients whose files had been archived, but who should have 
been tested for OSA, invite those patients back to the clinic for further testing, and 
determine how to ensure that people do return to the clinic in the future if they are 
identified as at risk for OSA. To do so, I reviewed 182 archived ABP patient files to 
identify those patients who demonstrated a risk of OSA during the initial screening 
process. Then, I contacted those patients and invited them back to the clinic for 
overnight pulse-oximetry, partly to determine how willing patients were to return to 
the clinic for OSA testing. I designed a script for contacting patients that emphasized 
the connection between hypertension and OSA and the possible benefits of treating 
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OSA for their overall health. Finally, I developed an improved ABP patient archive 
form in order to ensure that when a patient demonstrates a risk of OSA, their file would 
not be prematurely archived. Based on their Epworth Sleepiness Scale and STOP-BANG 
questionnaire scores, and their self-reported sleep issues, 48 of the 182 patients should 
have been invited back to the clinic for overnight pulse-oximetry to test for OSA. Of 
those, 20 were contacted successfully and 10 agreed to return to the clinic for pulse-ox. 
The conclusions from this study were that more than a quarter of the patients who 
initially visited the clinic for overnight ABP monitoring should have returned for pulse 
oximetry, a substantial proportion of patients were willing to return to the clinic for 
further testing, and that a new “Request to Archive ABP Patient File” form was 
necessary in the clinic to ensure that ABP patients demonstrating a risk for OSA were 
being identified and not archived.  
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INTRODUCTION 
Obstructive sleep apnea (OSA) is a common health concern that often goes 
undiagnosed; in 2010, it was reported that approximately 3% of Canadians over 18 and 
5% of Canadians over 45 have been diagnosed with OSA, and 26% of Canadian adults 
were at risk for OSA based on specific risk factors (Public Health Agency of Canada 
2009).   For example, there is an increased risk in certain populations, including males 
and post-menopausal women, overweight/obese people, the elderly, certain ethnic 
minorities, and those who have a history of OSA in their family (Academy of Sleep 
Medicine, 2008). Increased risk is most commonly associated with enlarged 
oropharyngeal structures, structures which comprise the middle portion of the throat 
between the soft palate and epiglottis. Genetic factors and obesity are both known to 
contribute to enlargement of these structures, factors which explain why the 
aforementioned populations have higher representation (Schellenberg et al., 2000).  
Many studies have attempted to find a direct causal link between OSA and various 
comorbidities due to the high prevalence of conditions such as high blood pressure 
(hypertension) in patients who also have OSA. The proportion of patients with both 
OSA and hypertension can be high (Cohen and Townsend, 2013; Friedman and Logan, 
2009; Kapur and Weaver, 2012; Marin et al., 2012). For example, one study found that 
the prevalence of OSA in adults with drug-resistant hypertension was 83% (Logan et al., 
2001). OSA was diagnosed in these cases when patients had an apnea-hypopnea index 
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(AHI) of greater than 10.  The AHI is a metric for scoring OSA severity based on the 
number of absent or decreased respirations per hour; an AHI of 5-15 is classified as mild 
OSA, an AHI of 15-30 is moderate, and an AHI of >30 is severe (Public Health Agency 
of Canada, 2009).  
There are many confounding variables that can contribute to both OSA and 
hypertension (or other comorbidities), making causal relationships difficult to confirm. 
Studies have shown that treatment for OSA using continuous positive airway pressure 
(CPAP) can lead to lower blood pressure in hypertensive patients (Haentjens et al., 
2007). CPAP is the typical treatment for OSA that consists of a mask worn over the nose 
and a machine that produces a continuous flow of air through the nasal passage, 
keeping the airway open (Canadian Lung Association, 2012) (Figure 1).  The fact that 
CPAP therapy has the potential to lower blood pressure suggests that OSA may in fact 
be causing, or at least contributing to, hypertension in some cases.  Due to the strong 
correlation between OSA and hypertension, and the fact that there is evidence of OSA 
contributing to hypertension, the Thompson Rivers University (TRU) Sleep Clinic has 
made efforts to screen all of those patients who are referred to the clinic for overnight 
ambulatory blood pressure (ABP) monitoring for OSA as well.  
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Figure 1. CPAP therapy involves a machine that pumps air continuously though a hose 
connected to a mask that is worn over the nose (Harvard Health Publications, 2013).  
 
Ambulatory blood pressure (ABP) monitoring is a method of measuring a patient’s 
blood pressure (BP) at set intervals overnight, as opposed to a one time measurement 
done in a physician’s office. Several physicians in Kamloops refer patients that display 
hypertension during the office-based test to the TRU Sleep Clinic for overnight 
monitoring. This allows the physician to view a patient’s BP overnight when a person 
with normal BP would usually experience a “dip” or temporary decrease in BP. A 
person with hypertension however, is often a “non-dipper”, therefore does not have the 
normal overnight drop in BP (Verdecchia, 1991). Non-dipping hypertension has also 
been directly connected to OSA and so the clinic could use this information as an 
indicator of possible OSA (Stergiou et al., 2013). ABP monitoring also tends to alleviate 
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false measurements as a result of “white coat hypertension”, the case where a patient 
has higher than usual BP readings in the doctor’s office (Anwar and White, 2001, Manci 
et al., 2011). ABP monitoring has been shown to be far more accurate for diagnosis 
compared to home or office-based blood pressure measurements (Hodgkinson et al., 
2011). 
At TRU, each patient who visits the clinic for ABP monitoring is asked to complete two 
standardized OSA screening questionnaires, the Epworth Sleepiness Scale (ESS) and the 
STOP-BANG questionnaire (see Appendix I & II), and is asked general questions about 
their sleeping habits. The ESS questionnaire was developed in 1991 by Dr. Murray 
Johns in order to measure daytime sleepiness, which is one of the clearest symptoms of 
OSA (Johns, 1991). The STOP-BANG questionnaire, or loud Snoring, Tiredness, 
Observed apnea, high blood Pressure (STOP)-Body-mass index, Age, Neck 
circumference, and Gender (BANG) questionnaire, is used to determine the likelihood 
of OSA based on other symptoms and risk factors of OSA including loud snoring, 
tiredness, high body-mass index etc. (Chung et al., 2013). By employing these methods, 
clinic personnel hope to get those patients who show a risk of OSA to return to the 
clinic after their ABP monitoring is complete to receive formal screening and possibly 
treatment for OSA.  
However, as my review of the archived ABP patient file revealed, there has been a lack 
of follow-through at the TRU Sleep Clinic with ABP patients who also showed signs of 
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OSA. Many of the ABP patients had ESS and STOP-BANG scores that would indicate 
that they might be suffering with OSA. Many times, no mention of this was made on 
the “Request to Archive Patient File” form. Sometimes, the student who conducted the 
appointment did note that the patient would be a good candidate for OSA, yet still 
requested to archive the file. As such, the patient would be advised to request a new 
referral to the clinic for OSA and their file archived. However, a new referral is not 
necessary to give a pulse oximetry test meaning that this should have been offered to 
the patient immediately. Pulse oximetry measures oxygen saturation in the blood and 
therefore reveals whether a patient is breathing effectively at night; this is how the TRU 
Sleep Clinic screens for OSA. 
The ABP patient archival process, with the requirement of a supervisor signature, was 
designed to ensure that students conducting patient appointments were archiving 
patient files when appropriate. This would ensure that each patient’s ABP results were 
sent to the doctor, that the patient did not have outstanding equipment loans, and that 
the student could make additional comments. The additional comments section was 
where I often found the information that the patient showed signs of OSA. However, 
despite this system, ABP patient files were still being archived prematurely, before the 
patient had been offered testing and treatment for OSA. What the document lacked was 
a section where the student recorded specific data regarding the patient’s risk for OSA; 
this would incorrectly demonstrate to the supervisor reviewing the request form that 
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the patient had received all the care that the clinic could provide and that the file should 
thus be archived. My goal was to determine how many archived ABP patients should 
have returned to the clinic for proper OSA testing, how to get those patients to return to 
the clinic for pulse oximetry, and how to ensure patients’ files are not prematurely 
archived in the future. 
MATERIALS AND METHODS 
In order to determine how many ABP patient files were prematurely archived, I 
reviewed all 182 archived files thoroughly over the course of a month. Each file took 
approximately 30 minutes to review, depending on the patient and the content of the 
file. I noted their ESS and STOP-BANG scores and their self-reported sleep issues. If 
their ESS score was above 10, their STOP-BANG score was above 2, and/or they 
reported loud snoring or daytime sleepiness, I included them in my contact list.  
Through my file review, I learned the issues with the process of archiving currently 
being used in the clinic and I developed a new “Request to Archive ABP Patient File” 
form to address those issues. I collaborated with the director of the Respiratory Therapy 
(RT) program at TRU and the RT students working in the clinic to determine what was 
needed on the new form.  I added a section to the form in which RT students who 
conduct appointments must report patients’ ESS and STOP-BANG scores, whether they 
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report any of the common symptoms of OSA, and whether patients are offered 
overnight pulse oximetry (See Appendix III).   
Once I determined which patients were to be contacted, I developed a script for 
contacting patients (approved by the TRU Human Ethics Review Board – File Number 
100374; See Appendix IV) that focused on the recognized connection between 
hypertension and OSA, and the possible benefits to their health if they were to be 
treated for OSA.  After contacting the patients and setting up appointments, I showed 
each patient how to use the pulse oximetry monitor overnight and instructed them to 
bring it back the following day. Pulse oximetry uses light waves to measure the relative 
concentrations of hemoglobin (HB) and oxyhemoglobin (O2Hb) in the blood by 
measuring the absorbance of the light waves, thus revealing the saturation of oxygen in 
the blood (Sinex, 1999).  
I then downloaded the data and calculated their KDI (Kamloops Desaturation Index) 
score to determine their level of risk. The desaturation index (DI) is the measurement 
usually used for pulse oximetry data analysis. DI calculates the number of times per 
hour that the oxygen saturation in the blood dropped by 4%. KDI is a calculation 
developed by the TRU sleep clinic as a more sensitive measure of whether a person is at 
risk for OSA. Instead of a drop by 4%, the KDI calculates the percentage of relevant time 
that the patient had a saturation value below 90% because that would indicate 
substantial disturbances in the patient’s breathing. KDI = DI [1 + (% <90/10)] where DI = 
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desaturation index; % <90 (as a decimal value) = the percentage of those desaturations 
that were below 90%. Any patient with a KDI value above 6 likely has at least mild OSA 
and, as that value increases, so does the probability of the presence of higher severity 
OSA. If the KDI value is below 6, this method is not sensitive enough to determine 
whether the patient is experiencing apneas and in this case, further testing is 
recommended.      
RESULTS AND DISCUSSION 
The review of the archived ABP patient files revealed that 26% (48/182) of the patients 
showed symptoms of OSA based on the previously mentioned criteria (Figure 2A). This 
is in agreement with the high correlation between hypertension and OSA that has been 
demonstrated in previous research (Cohen and Townsend, 2013; Friedman and Logan, 
2009; Kapur and Weaver, 2012; Logan et al., 2001; Marin et al., 2012). After learning the 
number of patients in the clinic that should have been formally tested for OSA and 
possibly treated, it was important to attempt to get those patients to return to the clinic 
to assess their sleep issues. I was concerned that contacting patients, who had already 
been diagnosed with high blood pressure to inform them that they also possibly have 
OSA and that they should return to the clinic for more testing, would be unsuccessful. 
The script I developed for contacting patients was designed to focus on the research 
showing that hypertension and OSA are highly correlated and that treating for OSA, 
when it is present, can effectively lower blood pressure.  
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Figure 2. Results of archived ABP patient file review and patient contact. 48/182 archived 
patients showed symptoms of OSA and should have been offered further testing (pulse 
oximetry) for OSA. 20/48 patients were successfully contacted and 10 agreed to return to the 
clinic for pulse oximetry. 4/10 patients had KDI scores over 6 and were advised to ask for a 
formal referral from their doctor for a CPAP trial. 
 
Some of the patients I attempted to contact had originally come in as early as 2008, so 
contacting them was particularly difficult because many had changed their contact 
information, moved, or were deceased. Of the 48 patients identified, I successfully 
contacted only 20, and out of these, 10 agreed to come back to the TRU Sleep Clinic for 
overnight pulse oximetry to screen for OSA (Figure 2B). Of the 10 people who 
underwent a pulse oximetry test, 4 had KDI values above the threshold (Figure 2C) and 
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were advised to seek a formal referral to the clinic for a CPAP trial. Confidentiality 
issues prevented me from following up with these patients regarding their actions. The 
other 6 patients were notified that their pulse oximetry results indicated that they 
probably did not have OSA; if they were still concerned with their sleep, I advised them 
to consider taking a polysomnogram at the hospital, a much more comprehensive 
overnight test, to identify other sleep issues. Overall, the 50% return rate was much 
higher than expected. I concluded that if patients understand the connection between 
hypertension and OSA, and the potential benefits to their health from treating OSA, 
they are usually willing to undergo more testing. Furthermore, if these facts were 
presented to the patient early, for example during their initial patient visit after they are 
referred to the clinic for ABP monitoring, and the testing was offered to them at that 
time, I predict that patients would be even more receptive to the additional test.   
The aspect of this project that I hope will make the largest improvement on the lack of 
follow-through identified herein is the new “Request to Archive ABP Patient File” form. 
The new form includes a section for students to report patients’ ESS and STOP-BANG 
scores as well as any sleep issues reported during the initial patient contact 
appointment. By including this information, the supervisor, who must sign the form 
before the file may be archived, will be able to determine whether the patient shows 
signs of OSA and, if so, if the patient was offered a pulse oximetry test. While reviewing 
files, I often noticed that RT students put notes in the file that the patient would be a 
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good candidate for OSA, yet files were still archived and students recorded that they 
would await a referral from the doctor. However, once a file is archived, it is not 
revisited by clinic personnel so if a referral from a doctor never arrived, this patient 
would not be offered testing. The new form will eliminate the possibility of ABP 
patients with signs of OSA being overlooked and the files being prematurely archived.     
CONCLUSION/FUTURE WORK 
The literature review for this project clearly revealed that hypertension and OSA are 
strongly correlated, as expected, and that hypertensive patients should always be 
screened for OSA. Since recent research has shown that treating OSA with CPAP can 
effectively lower blood pressure in hypertensive patients, it would appear these two 
conditions should also be treated together. This project was successful in identifying a 
major gap in the process of archiving files in the TRU Sleep Clinic, where ABP patients 
who also qualified for OSA were not being consistently offered formal screening for 
OSA. By illuminating this problem and developing the new “Request to Archive ABP 
Patient File” form, there will be an opportunity for this clinic to build its own database 
of patients who are being treated for both hypertension and OSA which will open up 
possibilities for future studies in the clinic. By continuing to study the connection 
between these two health problems, the TRU Sleep Clinic can be an example of positive 
change and raise awareness about the efficacy of testing for and treating hypertension 
and OSA simultaneously.  
12 
 
LITERATURE CITED: 
Anwar, Y. A., and White, W. B. (2001). “Ambulatory monitoring of blood 
pressure”. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Humana 
Press. 57-75. 
Chung, F., Yang, Y., and Liao, P. (2013). Predictive Performance of the STOP-Bang Score 
for Identifying Obstructive Sleep Apnea in Obese Patients. Obes. Surg. 23, 2050–2057. 
Cohen, D.L., and Townsend, R.R. (2013). Obstructive Sleep Apnea and Hypertension. J. 
Clin. Hypertens. 15, 703. 
Friedman, O., and Logan, A.G. (2009). The Price of Obstructive Sleep Apnea–Hypopnea: 
Hypertension and Other Ill Effects. Am. J. Hypertens. 22, 474–483. 
Haentjens, P., Van Meerhaeghe, A., Moscariello, A., De Weerdt, S., Poppe, K., Dupont, 
A., and Velkeniers, B. (2007). The impact of continuous positive airway pressure on 
blood pressure in patients with obstructive sleep apnea syndrome: evidence from a 
meta-analysis of placebo-controlled randomized trials. Arch. Intern. Med. 167, 757–764. 
Hodgkinson, J., Mant, J., Martin, U., Guo, B., Hobbs, F.D.R., Deeks, J.J., Heneghan, C., 
Roberts, N., and McManus, R.J. (2011). Relative effectiveness of clinic and home blood 
pressure monitoring compared with ambulatory blood pressure monitoring in 
diagnosis of hypertension: systematic review. BMJ 342, d3621–d3621. 
Johns, M.W. (1991). A New Method for Measuring Daytime Sleepiness: The Epworth 
Sleepiness Scale. Sleep 14, 540–545. 
Kapur, V.K., and Weaver, E.M. (2012). Filling in the Pieces of the Sleep Apnea–
Hypertension PuzzleThe Pieces of the Sleep Apnea–Hypertension Puzzle. JAMA 307, 
2197–2198. 
Logan, A.G., Perlikowski, S.M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., 
Leung, R.S., and Bradley, T.D. (2001). High prevalence of unrecognized sleep apnoea in 
drug-resistant hypertension. J. Hypertens. 19, 2271–2277. 
Mancia, G., Bombelli, M., Seravalle, G., & Grassi, G. (2011). Diagnosis and management 
of patients with white-coat and masked hypertension. Nature Reviews Cardiology. 8, 
686-693. 
13 
 
Marin, J.M., Agusti, A., Villar, I., Forner, M., Nieto, D., Carrizo, S.J., Barbe, F., Vicente, 
E., Ying, W., Nieto, F.J., et al. (2012). Association Between Treated and Untreated 
Obstructive Sleep Apnea and Risk of Hypertension. J. Am. Med. Assoc. 307, 2169–2176. 
Schellenberg, J.B., Maislin, G., and Schwab, R.J. (2000). Physical findings and the risk for 
obstructive sleep apnea: The importance of oropharyngeal structures. Am. J. Respir. 
Crit. Care Med. 162, 740–748. 
Sinex, J. E. (1999). Pulse oximetry: principles and limitations. Am. J. Emerg. Med. 17, 59-
66. 
 
Stergiou, G.S., Triantafyllidou, E., Cholidou, K., Kollias, A., Destounis, A., Nasothimiou, 
E.G., Markozannes, E., and Alchanatis, M. (2013). Asleep home blood pressure 
monitoring in obstructive sleep apnea. Blood Press. Monit. 18, 21–26. 
Unknown Author (2008). Academy of Sleep Medicine: Obstructive Sleep Apnea. 
http://www.aasmnet.org/resources/factsheets/sleepapnea.pdf (accessed February 21, 
2014). 
Unknown Author (2012). Canadian Lung Association: C.P.A.P. 
http://www.lung.ca/diseases-maladies/apnea-apnee/cpap-cpap/index_e.php (accessed 
April 26, 2014). 
Unknown Author (2009). Public Health Agency of Canada. What is the Impact of Sleep 
on Canadians: Fast Facts from the 2009 Canadian Community Health Survey - Sleep Apnea 
Rapid Response. http://www.phac-aspc.gc.ca/cd-mc/sleepapnea-apneesommeil/ff-rr-
2009-eng.php (accessed February 21, 2014). 
Verdecchia, P., Schillaci, G., and Porcellati, C. (1991). Dippers versus non-dippers. J. 
Hypertens. Supplement: official journal of the International Society of Hypertension 9, 
S42-4. 
Watson, S (2013). Harvard Health Publications: Weight loss, breathing devices still best for 
treating obstructive sleep apnea. http://www.health.harvard.edu/blog/weight-loss-
breathing-devices-still-best-for-treating-obstructive-sleep-apnea-201310026713 (accessed 
April 26, 2014). 
 
 
 
14 
 
APPENDIX I 
THOMPSON RIVERS UNIVERSITY 
CENTER FOR RESPIRATORY HEALTH AND SLEEP SCIENCE    
Room S301 900 McGill Rd, Kamloops,  BC    V2C 0C8  
Phone: 250-371-5952        Fax: 250-371-5771    Email: studentsleepclinic@tru.ca 
 
 
 
FORM #7:  ESS QUESTIONNAIRE                                                                  (5 min) 
 
PATIENT  Age  
DOB (mm/dd/yy)  Male / Female 
Student Name  Date  
 
Epworth Sleepiness Scale (ESS) 
 
How likely are you to doze off or fall asleep in the following situations (as opposed to 
just feeling tired)?  This refers to your normal/typical way of life in recent times.  Even if 
some of these situations have not occurred recently, imagine how they may affect you.   
 
Circle the appropriate number for each situation; 
 
Situation Never Slight 
chance 
Moderate 
chance 
High 
chance 
 
Sitting and reading 0 1 2 3 
Watching TV 0 1 2 3 
Sitting, inactive, in a public place (eg; theatre, 
meeting) 
0 1 2 3 
A passenger in a car for an hour, without a break 0 1 2 3 
Laying down in the afternoon 0 1 2 3 
Sitting and talking to someone 0 1 2 3 
Sitting quietly after lunch (without alcohol) 0 1 2 3 
Driving a car, stopped for a few minutes in traffic 0 1 2 3 
 
 
  Total Score:  _______ / 24 
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THOMPSON RIVERS UNIVERSITY 
CENTER FOR RESPIRATORY HEALTH AND SLEEP SCIENCE 
Room S301 900 McGill Rd, Kamloops,  BC    V2C 0C8 
Phone: 250-371-5952        Fax: 250-371-5771    Email: studentsleepclinic@tru.ca 
 
FORM #13:  REQUEST TO ARCHIVE ABP PATIENT FILE               
 
DATE: 
PATIENT           Male / Female 
DOB (mm/dd/yy)  Age  
Phone  H W C 
Preferred Contact #                                                                                                          
Email  
Address  City  
Province    Postal Code  
Referring Physician  Family Physician    
Initial Contact Date:  Last Contact Date:  
 
Results of ABP:    Normal         High Normal         Hypertension: circle one  
              (mild,  moderate,  severe)   
   
Check reason for request to archive patient file: 
    Patient does not wish to be contacted again by the clinic 
    Phone number is no longer in service 
    New phone number cannot be determined after call to family physician     
    Patient is complete and has not made contact / returned calls within the last year. 
    Patient is deceased Date:        
    Patient was referred, but has not responded to initial contact in 6 months.  
       (Patient now requires new referral) 
Check off as ascertained from patient file and documentation: 
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   Patient does NOT have TRU equipment 
 Date of Equipment Return:   _____________________________           
   Patient DOES have the following equipment; 
     CPAP       Humidifier 
     Mask       Pulse Oximeter 
 
Sleep Information: 
 
ESS Score:    __________ 
 
Stop-Bang Score:     __________ 
 
Was the patient encouraged to undergo overnight pulse-oximetry? Yes  No 
 
Did the patient report: 
 
Snoring      Yes   No 
Bruxism     Yes   No 
Episodes of apnea    Yes   No 
Restless sleep     Yes   No 
Daytime fatigue    Yes   No 
 
 
 
Comments:_______________________________________________________________________ 
________________________________________________________________________________ 
________________________________________________________________________________ 
 
_____________________________________  _______________________________________                                                  
          Print Student Name                 Signature, SRT 
 
_____________________________________  _______________________________________                                                  
             Faculty Name                            Faculty Signature  
 
    Request Accepted  Date of Archive:  ___________________________ 
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